News

CarMax's Earnings Report: Insights and Expectations Revealed

CarMax's Earnings Report: Insights and Expectations Revealed

CarMax Earnings Release Overview

CarMax (NYSE: KMX) is preparing to unveil its quarterly earnings report, creating anticipation among investors. This detailed overview highlights key insights and expectations ahead of the announcement, helping investors make informed decisions.

Market Anticipations

Analysts predict that CarMax will post an earnings per share (EPS) of $0.32 in its upcoming announcement. Investors are eager to see if the company can exceed this estimate and, more importantly, provide positive guidance for the following quarter. Guidance can significantly impact stock prices, often more than just beating or missing earnings estimates.

Recent Earnings Performance

In its previous quarter, CarMax reported an EPS that fell short by $0.39, resulting in a 1.62% drop in share price the following day. The recent history of performance offers valuable context for understanding market sentiments around the upcoming earnings release.

Past Earnings: Key Metrics

Examining CarMax’s recent earnings performance helps set the stage for future predictions. In the last reported quarters, the company has encountered fluctuations in EPS estimates and actual figures, which directly influences stock performance.

Current Stock Performance

As of the latest trading session, CarMax shares were valued at $40.63, marking a decline of approximately 51.76% over the past year. This decline in stock value has led many long-term investors to approach the upcoming earnings report with caution and bearish sentiments.

Analyst Insights on CarMax

Staying updated with market trends and sentiments is crucial for investors in the automotive retail sector. Recent analysis shows that CarMax has received a total of 20 ratings from analysts, with a consensus rating of Neutral, and an average one-year price target of $46.4, indicating a potential upside of 14.2%.

Comparative Analysis with Peers

When analyzing the market positioning of CarMax, it is insightful to compare its performance with peers in the industry, such as Group 1 Automotive, Asbury Automotive Group, and AutoNation. This comparative perspective reveals relative performance expectations and highlights CarMax's standing.

Peer Ratings Overview

  • Group 1 Automotive shows a Neutral outlook, with a significant one-year price target of $451.67, suggesting a potential upside of 1011.67%.
  • Asbury Automotive Group also maintains a Neutral expectation, with an average price target of $247.75, suggesting a potential upside of 509.77%.
  • AutoNation is rated Outperform, with an average price target of $246.62, reflecting a potential upside of 506.99%.

Summary of Peer Performance

This summary of peer metrics for prominent automotive companies sheds light on market competition and expectations:

Company Consensus Revenue Growth Gross Profit Return on Equity
CarMax Neutral -5.97% $717.67M 1.53%
Group 1 Automotive Neutral 10.75% $919.70M 0.41%
Asbury Automotive Group Neutral 13.31% $802.50M 3.84%
AutoNation Outperform 6.85% $1.24B 8.64%

Key Takeaway: CarMax currently ranks low in revenue growth compared to its industry peers, positioning itself in a challenging landscape.

Company Overview

Founded in 1993, CarMax has grown to be the leading retailer of used vehicles in the U.S. The company operates over 250 locations, handling both sales and financing of pre-owned and new cars. Fiscal data reveals that used vehicle sales contributed significantly to revenue, marking a notable industry presence despite only achieving around 3.7% market share in the U.S. for vehicles up to ten years old.

CarMax’s Economic Impact

Market Capitalization: CarMax’s market cap indicates challenges, as it is lower than industry averages.

Revenue Trends: The company has faced a revenue decline of approximately -5.97% over recent months, impacting its financial growth expectations.

Financial Health: CarMax showcases a strong net margin of 1.45%, highlighting effective cost management strategies.

Return Metrics: The return on equity stands at 1.53%, demonstrating effective utilization of equity capital.

Debt Management Strategy: With a debt-to-equity ratio of 3.09, CarMax opts for a conservative financial strategy, reducing reliance on debt financing.

Frequently Asked Questions

What is the anticipated EPS for CarMax?

Analysts forecast that CarMax will report an earnings per share (EPS) of $0.32.

How did CarMax perform in its last earnings report?

CarMax's last earnings report showed an EPS miss by $0.39, resulting in a 1.62% drop in stock price the following day.

What is the current stock price of CarMax?

CarMax shares were trading at $40.63 as of the most recent update.

How does CarMax compare to its peers?

CarMax ranks lower in revenue growth compared to its peers but maintains a competitive position in terms of net margin.

When is CarMax releasing its earnings report?

CarMax is set to release its quarterly earnings report on December 18, 2025.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 9

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 3

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 4

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 4

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 5

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 6

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 3

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading

Top 5 Most Recently Viewed Articles

SportsMed Physical Therapy Expands with New Clinic Opening

Updated Category News Views 275

SportsMed Physical Therapy Expands Its Reach SportsMed Physical Therapy, a prominent name in outpatient rehabilitation and wellness, is excited to announce the launch of its latest clinic in Bellville, New Jersey. With this addition, the total count of SportsMed facilities has now reached an impressive 48 locations, significantly improving patient access to comprehensive...

Continue Reading
Ispire Tech Stock Dips to Record Low: A Pathway to Recovery

Updated Category News Views 233

Ispire Tech Stock Declines Significantly In recent market developments, Ispire Tech's stock has fallen to an alarming 52-week low of $4.99. This marks a steep decrease of 88% from its previous peak of $12.86. The significant drop has raised eyebrows among investors as the company navigates a challenging economic landscape. Ispire Technology, known for its innovative...

Continue Reading
Strategic Investment by BrainsWay to Enhance Mental Health Solutions

Updated Category News Views 165

BrainsWay's Expansion Plans and Strategic Investment This investment marks BrainsWay’s entrance into the market for mental health therapies that can be administered outside of a clinic, including at home. Neurolief’s breakthrough Proliv™Rx device is pending Premarket Approval from the U.S. FDA, and if granted, it will set a precedent as the first FDA-cleared medical...

Continue Reading
Brian Wagner Joins Saltbox Mgmt as Chief Revenue Officer

Updated Category News Views 192

Saltbox Mgmt Welcomes Brian Wagner as Chief Revenue Officer Saltbox Mgmt, a leader in unified commerce transformations within the Salesforce ecosystem, is excited to announce the appointment of Brian Wagner as its Chief Revenue Officer. Wagner is a seasoned veteran in the enterprise SaaS industry, bringing with him more than two decades of experience in sales leadership....

Continue Reading
Unlocking Holiday Potential: Empowering Small Businesses

Updated Category News Views 199

Leveraging Payment Technology for Small Business Success As the holiday season approaches, small businesses are presented with exciting new avenues to attract customers and increase revenue. A recent study highlights that small businesses can greatly benefit from advances in payment technology, presenting opportunities for local retailers to capture a larger portion of...

Continue Reading